Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection-Reference-Cited by-同舟云学术

Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection

Published:2022-06-15 Issue:9 Volume:52 Page:754-761
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Hagiwara Satoru¹,Nishida Naoshi¹,Ida Hiroshi¹,Ueshima Kazuomi¹,Minami Yasunori¹,Takita Masahiro¹,Aoki Tomoko¹,Morita Masahiro¹,Chishina Hirokazu¹,Komeda Yoriaki¹,Yoshida Akihiro¹,Hayashi Hidetoshi²,Nakagawa Kazuhiko²,Kudo Masatoshi¹

Affiliation:

1. Department of Gastroenterology and Hepatology Kindai University Faculty of Medicine Osaka Japan

2. Department of Medical Oncology Kindai University Faculty of Medicine Osaka Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13798

Reference18 articles.

1. Kinetics and Risk of De Novo Hepatitis B Infection in HBsAg–Negative Patients Undergoing Cytotoxic Chemotherapy

2. Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies

3. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis

4. Managing HBV in patients with impaired immunity

5. Characteristic Pattern of Reactivation of Hepatitis B Virus during Chemotherapy for Solid Cancers

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune‐related hepatitis in non–small cell lung cancer patients with chronic hepatitis B;Cancer;2024-01-02

2. Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis;Infectious Diseases of Poverty;2023-09-22

3. The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB;Frontiers in Pharmacology;2023-04-24

4. Advances in Immunotherapy for Hepatocellular Carcinoma;Cancers;2023-03-30

5. Pembrolizumab-induced acute exacerbation of hepatitis D;Zeitschrift für Gastroenterologie;2022-11-14